CSRXP APPLAUDS SENATE FOR MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE AND LOWERING PRESCRIPTION DRUG PRICES

08-7-2022 Press Release

Drug Pricing Solutions in Inflation Reduction Act of 2022 Will Help Crack Down on the Pharmaceutical Industry’s Egregious Practices, Deliver Relief for American Patients For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Sunday on the U.S. Senate passage of the Inflation Reduction Act […]

CSRXP COMMENDS ADVANCEMENT OF BILL TO BOOST AGENCY COOPERATION TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

07-28-2022 Press Release

Bipartisan Interagency Patent Coordination and Improvement Act of 2022 Will Help Hold Brand Name Drug Companies Accountable, Support Pharmaceutical Competition For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday following the passage of the Interagency Patent Coordination and Improvement Act of 2022 in […]

CSRXP: INSULIN ACT MAY PROVIDE SHORT TERM RELIEF FOR SOME PATIENTS BUT WON’T ADDRESS ROOT CAUSE OF OUT-OF-CONTROL DRUG PRICES

07-19-2022 Press Release

Congress Must Advance Bipartisan, Market-Based Solutions to Hold Big Pharma Accountable for Egregious Anti-Competitive and Pricing Practices to Lower Rx Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act. […]

CSRXP: BIG PHARMA BRAZENLY INCREASES PRICES ON MORE THAN 100 DRUGS TO START JULY PRICE-GOUGING

07-12-2022 Press Release

Brand Name Drug Companies Begin Second Round of Biannual Price Hikes While Pointing Fingers at Others to Evade Accountability For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday reacting to a first batch of price increases on brand name drugs from manufacturers as […]

CSRXP APPLAUDS MOMENTUM TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES

06-29-2022 Press Release

Congress Should Swiftly Advance Solutions to Deliver Relief for Millions of Americans Hurt By Brand Name Drug Companies’ Egregious Practices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday reacting to reports Congressional leaders will introduce a revised reconciliation package with a significant […]

CSRXP AD CAMPAIGN: AMERICAN PEOPLE HAVE WAITED LONG ENOUGH; CONGRESS MUST HOLD BIG PHARMA ACCOUNTABLE

04-28-2022 Press Release

Seven-Figure Campaign Calls on Lawmakers to Reject Big Pharma’s Blame Game and Deliver on Repeated Promises to Lower Prescription Drug Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) announced the start of a five-month, seven-figure advertising campaign Thursday in Washington, D.C. and target states […]

CSRXP: FINALIZED CMS COVERAGE DECISION FOR ADUHELM PROTECTS SENIORS AND TAXPAYERS FROM BIG PHARMA PRICE-GOUGING

04-8-2022 Press Release

Decision Appropriately Balances Access to Treatment with the Need for More Data on the Clinical Value for Patients For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in reaction to the finalized National Coverage Determination decision for monoclonal antibodies for the treatment of […]

CSRXP COMMENDS PRESIDENT BIDEN FOR RENEWING COMMITMENT TO LOWERING DRUG PRICES, CONGRESS MUST ACT

03-2-2022 Press Release

Lawmakers Must Deliver on Repeated Promises to Hold Big Pharma Accountable Following Another State of the Union Call for Action For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday in response to President Biden once again calling for Congress to advance solutions to […]

CSRXP STATEMENT ON CONFIRMATION OF DR. ROBERT CALIFF AS COMMISSIONER OF U.S. FOOD AND DRUG ADMINISTRATION

02-15-2022 Press Release

FDA Can Play a Critical Role in Holding Big Pharma Accountable and Promoting Competition, Transparency and Value For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the U.S. Senate confirmation of Dr. Robert M. Califf to serve as commissioner of the U.S. Food […]

CSRXP POLL: VOTERS SEE THROUGH BIG PHARMA’S BLAME GAME, WANT WASHINGTON TO LOWER DRUG PRICES & HOLD DRUG COMPANIES ACCOUNTABLE

02-7-2022 Press Release

Broad Majorities of Americans Blame Pharmaceutical Industry for Out-of-Control Drug Prices and Support Market-Based Solutions to Boost Affordability, Competition and Value For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the results of a national survey conducted by Morning Consult today. “Voters overwhelmingly view out-of-control prescription […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.